Loading clinical trials...
Loading clinical trials...
The prevalence of ESBL Klebsiella pneumonia was higher in patient with renal replacement therapy.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Inje University
NCT07656168 · ESRD (End-Stage Renal Disease), Maintenance Hemodialysis
NCT07348237 · Chronic Kidney Failure, End-Stage Renal Disease, and more
NCT04634916 · Kidney Disease, End-Stage, End-stage Renal Disease, and more
NCT06933472 · Hyperphosphatemia, Chronic Kidney Disease, Receiving Dialysis, and more
NCT05931276 · End-Stage Kidney Disease, End-Stage Renal Disease
Inje University Seoul Paik hospital Instituional Board Review
Seoul, Je Dong 2ga, Jung Gu
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions